Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

June 30, 2015

Conditions
Hypertension
Interventions
DEVICE

Renal Denervation

percutaneous renal denervation using the Vessix RF balloon catheter

Trial Locations (26)

1023

Auckland City Hospital, Grafton

Mercy Angiography Unit Ltd, Auckland

1211

University Hospital of Geneva, Cardiology Center, Geneva

2010

St. Vincent's Hospital, Sydney

3168

Monash Cardiovascular Research Centre (Monash Heart), Clayton

4020

AKH Linz, Linz

4032

The Prince Charles Hospital, Cardiology Clinical Research Centre, Brisbane

5000

Royal Adelaide Hospital, Adelaide

5042

Flinders Medical Centre, Bedford Park

8091

Switzerland University Hospital Clinic for Cardiology, Zurich

10365

Vascular Center Berlin, Ev. Königin Elisabeth Hospital, Berlin

22527

Hamburg University Cardiovascular Center, Hamburg

45141

St. Vincenz Krankenhaus Abt. Kardiologie, Essen

60389

CardioVascular Center, Sankt Katharinen Krakenhaus, Frankfurt

65812

Kardiologische Praxis Main-Taunus, Bad Soden/Taunus

80636

German Heart Center Munich, Münich

99437

Zentralklinik Bad Berka GmbH, Bad Berka

A-5020

Salzburger Landeskliniken Universitats Krankenhaus, Salzburg

Unknown

OLV Ziekenhuis, Aalst

Cliniques Universiaires Saint-Luc, Brussels

Hôpital Européen Georges Pompidou, Paris

F-31076

Clinic Pasteur, Toulouse

D-66421

Saarland University Hospital Department of Internal Medicine III Non-surgical Intensive Care, Cardiology and Angiology, Homburg/Saar

04109

University Leipzig, Leipzig

1105AZ

Academic Medical Center, Amsterdam

3015CE

Erasmus Medical Center-Thorax Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY